Therapeutic role of TGF-beta-neutralizing antibody in mouse cyclosporin A nephropathy: morphologic improvement associated with functional preservation.
about
Molecular mechanisms of renal blood flow autoregulationAnti-transforming growth factor ß antibody treatment rescues bone loss and prevents breast cancer metastasis to boneLack of endothelial nitric-oxide synthase leads to progressive focal renal injuryDonor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts.Aberrant Transforming Growth Factor-β Activation Recruits Mesenchymal Stem Cells During Prostatic Hyperplasia.Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β.Crosstalk between Smad and Mitogen-Activated Protein Kinases for the Regulation of Apoptosis in Cyclosporine A- Induced Renal Tubular Injury.Increased antitumor effects using IL-2 with anti-TGF-β reveals competition between mouse NK and CD8 T cells.Cysteine-rich protein 61 plays a proinflammatory role in obstructive kidney fibrosis.Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in miceProtection from obesity and diabetes by blockade of TGF-β/Smad3 signalingIdentification of a microRNA signature in renal fibrosis: role of miR-21.A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis.Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action.Experimental strategies to reverse chronic renal disease.TGF-β/Smad3 Signaling Regulates Brown Adipocyte Induction in White Adipose Tissue.Anti-TGF-β Antibody, 1D11, Ameliorates Glomerular Fibrosis in Mouse Models after the Onset of Proteinuria.Deleting the TGF-β receptor attenuates acute proximal tubule injury.Transforming growth factor β-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis.Dual roles of immunoregulatory cytokine TGF-beta in the pathogenesis of autoimmunity-mediated organ damageTransforming growth factor-β inhibition and endothelin receptor blockade in rats with monocrotaline-induced pulmonary hypertension.Therapeutic potential of TGF-beta inhibition in chronic renal failure.New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone.Proximal tubule PPARα attenuates renal fibrosis and inflammation caused by unilateral ureteral obstruction.Established and newly proposed mechanisms of chronic cyclosporine nephropathyIntegrin-mediated transforming growth factor-beta activation, a potential therapeutic target in fibrogenic disorders.Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in miceTGF-β1 mediates sirolimus and cyclosporine A-induced alteration of barrier function in renal epithelial cells via a noncanonical ERK1/2 signaling pathway.Differential regulation of VEGF by TGF-beta and hypoxia in rat proximal tubular cells.Sirolimus enhances cyclosporine a-induced cytotoxicity in human renal glomerular mesangial cellsKey roles for transforming growth factor beta in melanocyte stem cell maintenanceDifferent renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy.Cyclosporin a induces renal episodic hypoxia.Nitric oxide induces TIMP-1 expression by activating the transforming growth factor beta-Smad signaling pathway.Prevention of renal apoB retention is protective against diabetic nephropathy: role of TGF-β inhibition.Blocking TGF-β and β-Catenin Epithelial Crosstalk Exacerbates CKD.TGF-β1 monoclonal antibody: Assessment of embryo-fetal toxicity in rats and rabbits.Transforming growth factor-beta regulates house dust mite-induced allergic airway inflammation but not airway remodeling.The effects of cyclosporin A and Heteropterys tomentosa on the rat liver.
P2860
Q26825286-CB01B69E-F8CB-4E15-A3B4-6D89A9D167D4Q28742851-397C3867-7768-4654-8788-B70E4490C7ECQ30442482-FD7CEF89-76ED-49E6-8D06-AA9E6E257D10Q33561691-32586EEB-A042-48F2-9265-D50A596664B7Q33722426-EBA72B6A-991C-400B-9723-58CD7D038C67Q34162142-09378391-5511-4FA9-8A2A-532039EE647FQ34217266-3DE700BB-AA70-4751-83AA-77BA950D60E9Q34563034-A4219B75-56D4-44DD-9358-55D55294B842Q34606850-C8C4B428-5C2A-4795-A6D1-081384B8C05CQ34624546-AA4692C4-B3FD-41FC-8EF7-144D286A6228Q35203175-C7D72FF6-9880-4C40-B01C-8947D16EEF5CQ35326035-FB88D426-3A05-4EBD-A48A-59843E1A2043Q35669295-CFCA78A4-BCAC-4EB5-8B13-A38EEAE98BA5Q35794379-36660E12-BB73-49CA-BFFE-C4A20D9DEC7FQ35883541-CFB453A2-3D35-41EB-A4B1-20EE283974D2Q35971803-0578D587-6244-48CD-9CB6-1ACB3D45CF18Q36019916-AC7A5FBE-A72E-42AA-925C-F1B76FDB6E4BQ36426085-70A491A2-166B-4D09-8A4E-5634F67B11A4Q36511515-0E5DBF31-FFA3-4D83-B0D4-19D9111CC368Q36536931-33D2AC80-E16E-44AD-966D-042534549DCAQ36563572-51030AF6-58FC-47EF-82ED-D3B5E84C6DCAQ36739752-DF87CF49-4CA8-444D-A782-FB8AA0B56BC2Q36788871-55A7F05A-49A1-4DB5-A248-F3076EE65C0EQ37142522-AD5AEE29-C74F-4E9D-80E1-B73F888FA804Q37232923-07C83C0D-A39F-4479-95EC-7BAE1ABCDF88Q37362030-BBE311A1-890E-45A1-941F-C37B2B02E3F7Q37624843-D009BCFD-21E5-4412-86FC-436706B62EDEQ39481525-3006C42B-727B-42F8-AFE1-DBDC6C11E8BEQ40547600-AD95F771-29E1-4C9C-9852-190E8BC5645BQ40793003-42CEFEA4-D5B1-4588-BA8B-00956C98B0EEQ42324335-E7A4D0F6-577D-4FA2-A9D8-8132E8EFB83CQ43995286-779AD4EB-E294-4B32-8C96-960EF9F283AFQ44602862-E71BDDEE-617E-402B-A306-167ACCD00694Q45858755-56E1C780-472F-4028-A88C-4E4F7BE98EA5Q46720418-C609D667-63BA-44E6-8326-7A15B41E83B0Q47768797-CEBC77F9-2FC6-4BE8-9FC6-847D69263ED7Q47828924-FE8D92CE-B835-4529-9E54-81C1BC4B508DQ50483893-2054FD93-F1B4-4E76-B011-7E6DCFF4C5FDQ53507300-198A2E17-A701-4FFB-B767-354376F8BDFDQ53570949-E4458A7D-B553-44E9-A609-5BB1A5FFA279
P2860
Therapeutic role of TGF-beta-neutralizing antibody in mouse cyclosporin A nephropathy: morphologic improvement associated with functional preservation.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Therapeutic role of TGF-beta-n ...... with functional preservation.
@en
Therapeutic role of TGF-beta-n ...... with functional preservation.
@nl
type
label
Therapeutic role of TGF-beta-n ...... with functional preservation.
@en
Therapeutic role of TGF-beta-n ...... with functional preservation.
@nl
prefLabel
Therapeutic role of TGF-beta-n ...... with functional preservation.
@en
Therapeutic role of TGF-beta-n ...... with functional preservation.
@nl
P2093
P1476
Therapeutic role of TGF-beta-n ...... with functional preservation.
@en
P2093
Bruce Pratt
Lina Karetskaya
Sharda Jha
Steven Ledbetter
P304
P356
10.1097/01.ASN.0000042168.43665.9B
P577
2003-02-01T00:00:00Z